Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2010
11/24/2010EP2252594A2 5-fluoro pyrimidine derivatives as fungicides
11/24/2010EP2252593A1 Substituted pyridazine derivatives which have histamine h3 antagonist activity
11/24/2010CN1956974B 2-substituted pyrimidines and their use as pesticides
11/24/2010CN1925859B 4-(sulfanyl-pyrimidin-4-ylmethyl)-morpholine derivatives and related compounds as GABA receptor ligands for the treatment of anxiety, depression and epilepsy
11/24/2010CN1913900B Amino bustituted diaryl[a,d]cycloheptene analogs as muscarinic agonists and methods of treatment of neuropsychiatric disorders
11/24/2010CN1897937B 2-(3,4-dimethylphenyl)-4-{[2-hydroxy-3'-(1h-tetrazol-5-yl)biphenyl-3-yl]-hydrazono}-5-methyl-2,4-dihydropyrazol-3-one choline
11/24/2010CN1880304B Triamide-substituted indoles, benzofuranes and benzothiophenes
11/24/2010CN101896480A Tetrazole derivatives as modulators of metabotropic glutamate receptors (MGLURS)
11/24/2010CN101896472A HEDGEHOG pathway antagonists and therapeutic applications thereof
11/24/2010CN101896471A Fluoroalkyl substituted benzimidazole cannabinoid agonists
11/24/2010CN101896470A Dual-acting benzoimidazole derivative and their use as antihypertensive agents
11/24/2010CN101896465A Cannabinoid receptor modulators
11/24/2010CN101891690A Synthesis method of N-substituted-4-amino-quinazoline compound
11/24/2010CN101891668A L-prolinamide derivative, preparation method and application of same
11/24/2010CN101890018A Tyrosine protein kinase inhibitor and preparation method thereof
11/24/2010CN101175722B Azetidine derivatives as ccr-3 receptor antagonists
11/24/2010CN101171076B Affinity adsorbents for factor viii and von willebrand's factor
11/24/2010CN101085773B Polyamide bisbenzimidazole compound, preparation method and application thereof
11/23/2010US7838683 Synthesis of irbesartan
11/23/2010US7838681 Synthesis of substituted heterocyclic compounds
11/23/2010US7838675 Asthma, allergic rhinitis, COPD, inflammatory bowel disease, osteoarthritis, osteoporosis, rheumatoid arthritis, psoriasis, or cancer; N-[2-[[(2,3-difluorophenyl)methyl]thio]-6-[2-hydroxy-1-(hydroxymethyl)ethoxy]-4-pyrimidinyl]-1-azetidinesulfonamide for example
11/23/2010US7838537 Viral polymerase inhibitors
11/23/2010US7838525 modulators of glucose metabolism, GPCR, RUP3; metabolic disorders and complications thereof such as diabetes and obesity; 4-[5-Cyano-6-(6-methylsulfanyl-pyridin-3-ylamino)-pyrimidin-4-yloxy]-piperidine-1-carboxylic acid tert-butyl ester
11/23/2010US7838520 Inhibitors of histone deacetylase
11/23/2010US7838518 1-(4-methoxynaphthalene-1-sulfonyl)-2,3-dihydro-1H-indole-3-carboxylic acid [2-(1-methyl-pyrrolidin-2-yl)-ethyl]amide; selective affinity for 5-HT6 receptor; psychosis, schizophrenia, depression, neurological disorders, cognitive enhancement, Parkinson's disease, ALS, Alzheimer's, Huntington's disease
11/23/2010CA2487489C Mitotic kinesin inhibitors
11/18/2010WO2010132852A2 Protease inhibitors
11/18/2010WO2010132810A1 Deuterium modified benzimidazoles
11/18/2010WO2010132684A2 Inhibitors of inv(16) leukemia
11/18/2010WO2010132601A1 Antiviral compounds
11/18/2010WO2010132598A1 Heteroaryl compounds as pikk inhibitors
11/18/2010WO2010132538A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
11/18/2010WO2010131881A2 Bifunctional organic chiral catalyst compound with superior stereoselectivity, method for preparing same, and method for preparing chiral amino acids from azlactone using same
11/18/2010WO2010130944A1 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010WO2010130900A2 Triaminopyrimidine derivatives as cdc25 phosphatase inhibitors
11/18/2010WO2010130638A1 Sulfonamide compounds, pharmaceutical compositions and uses thereof
11/18/2010WO2010130178A1 Acrylamide derivative and use thereof in manufacture of medicament
11/18/2010WO2010077798A3 Stereoselective synthesis of piperidine derivatives
11/18/2010WO2010071846A3 Compounds for treating neuropsychiatric conditions
11/18/2010WO2010059611A3 Inhibitors of diacylglycerol acyltransferase
11/18/2010WO2010056644A8 1-(arylsulfonyl)-4-(piperazin-1-yl)-1h-benzimidazoles as 5-hydroxytryptamine-6 ligands
11/18/2010WO2010049952A3 A novel process for the preparation of eletriptan
11/18/2010WO2010036613A8 Novel cyclic benzimidazole derivatives useful anti-diabetic agents
11/18/2010WO2010033543A3 Substituted benzamides as cannabinoid receptor ligands
11/18/2010WO2009156735A3 New therapeutic agents
11/18/2010US20100292473 Process for preparing (2r,3s/2s,3r)-2-(2,4-difluorophenyl)-3-(5-fluoropyrimidin-4-yl)-1-(1h-1,2,4-triazol-1-yl)butan-2-ol
11/18/2010US20100292465 Catalysts containing n-heterocyclic carbenes for enantioselective synthesis
11/18/2010US20100292290 Novel process to prepare almotriptan
11/18/2010US20100292286 Crystalline imidazole-5-carboxylic acid derivative
11/18/2010US20100292263 Cgrp receptor antagonists with tertiary amide, sulfonamide, carbamite and urea groups
11/18/2010US20100292258 Substituted aromatic heterocyclic compounds as fungicides
11/18/2010US20100292252 Vinyl-aryl derivatives for inflammation and immune-related uses
11/18/2010US20100292249 Manufacture of rimcazole
11/18/2010US20100292244 Hydroxylated pyrimidyl cyclopentane as akt protein kinase inhibitor
11/18/2010US20100292234 Triazole fused heteroaryl compounds and methods of use thereof
11/18/2010US20100292219 Tertiary amine substituted peptides useful as inhibitors of hcv replication
11/18/2010US20100292207 Substituted indazole derivatives active as kinase inhibitors
11/18/2010US20100292205 Pyrimidone Compounds As GSK-3 Inhibitors
11/18/2010US20100292190 Novel tubulin polymerisation inhibitors
11/18/2010US20100292187 Methods for treating hepatitis c
11/18/2010US20100291025 Indazole inhibitors of tyrosine kinase
11/18/2010US20100290997 Imaging Agents and Methods
11/18/2010CA2761660A1 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof, and therapeutic use thereof
11/18/2010CA2761258A1 Antiviral compounds
11/18/2010CA2760778A1 Heteroaryl compounds as pikk inhibitors
11/18/2010CA2760205A1 Fused tricyclic aryl compounds useful for the treatment of viral diseases
11/17/2010EP2251339A2 Compounds
11/17/2010EP2251336A1 Hydrazide compounds as intermediates of pesticides
11/17/2010EP2251334A1 Labeling reagents and labeled analytes
11/17/2010EP2251327A2 Heterocyclic inhibitors of MEK and methods of use thereof
11/17/2010EP2250168A2 Angiotensin ii receptor antagonists
11/17/2010EP2250167A1 Arylmethylidene heterocycles as novel analgesics
11/17/2010EP2250164A2 Angiotensin ii receptor blocker derivatives
11/17/2010EP2250163A1 Hepatitis c virus inhibitors
11/17/2010EP2250162A2 Amide derivatives as positive allosteric modulators and methods of use thereof
11/17/2010EP2250158A2 Angiotensin ii receptor antagonists
11/17/2010EP2250157A1 Novel heterocyclic compounds
11/17/2010EP2170260B1 Azo derivatives containing a pyrazolinone unit for dyeing keratin fibres
11/17/2010EP1928861B1 4- (ih-indazol-5-yl-amino)-quinazoline compounds as erbb receptor tyrosine kinase inhibitors for the treatment of cancer
11/17/2010EP1907860B1 Mass labels
11/17/2010EP1899296B1 Histamine-3 receptor antagonists
11/17/2010EP1491206B1 Use of peptide derivatives for inducing cell differentiation
11/17/2010CN101889004A Inhibitors of protein kinases
11/17/2010CN101885722A Heterocycle alkyne and benzene compound, medicinal composition and application thereof
11/17/2010CN101885698A Pyrrolyl acrylamide compound and application thereof to synthesis of sunitinib
11/16/2010US7834182 histamine H3 receptor antagonists; metabolic disorders, sleep disorders, cardiovascular disorders, alcoholism, drug addiction, memory disorders, Alzheimer's, Parkinson's disease; 2-(4-piperidinylpiperidinyl)pyrimidine compounds such as 2-[(4-piperidin-1-yl)piperidin-1-yl]-5-(3-pyridyl)pyrimidine
11/16/2010US7834049 Integrin expression inhibitor
11/16/2010US7834047 Arylsulfonamides and uses related thereto
11/16/2010US7834044 Substituted-2-imidazoles
11/16/2010US7834021 3-aminopyrrolidine derivatives as modulators of chemokine receptors
11/16/2010US7834017 Melanocortin receptor modulators; sexual disorders, obesity, cachexia, eating disorders; for example 1,4-bis(2-amino-3-p-tolyl-propionyl)-2-isobutyl-5-(4-(2-aminoethylamino)butyl)piperazine
11/16/2010US7834016 breast cancer, prostate cancer, and colon cancer; indole, indoline, indol-2-one, or benzimidazoline based compounds having arylamine groups, for example 1-(pyrid-4-ylamino)-4-(2-(indol-3-yl)ethylamino)benzene
11/16/2010US7834014 Parkinson's disease; [2-(7-amino-2-furan-2-yl-[1,2,4]triazolo[1,5-a][1,3,5]triazin-5-yl)-octahydro-pyrido[1,2-a]pyrazin-7-yl]-methanol;
11/16/2010US7834007 Calcitonin gene-related peptide (CGRP); migraines; amido- and urea or carbamate functional compounds containing piperidine and one of indazolyl, benzotriazolyl, or benzooxazolin-2-one rings
11/16/2010US7834004 N-sulfonyl heterocyclic ring such as piperazine connected via sulfonyl group to another fused heterocyclic ring such as benzothiophene or indoline; peroxisome proliferator-activated receptor (PPAR); obesity, diabetes, hyperinsulinemia, metabolic syndrome X, polycystic ovary syndrome
11/16/2010US7834000 CGRP receptor antagonists
11/16/2010US7833999 histamine H3 receptor modulators; obesity, diabetes and central nervous system diseases such as vigilance and sleep disorders; e.g. (+)-2-(cyclohexylmethyl)-N-[2-(1-methylpyrrolidin-2-yl)ethyl] -1,2,3 ,4-tetrahydroisoquinoline-7-sulfonamide
11/16/2010US7833991 Amine compound and use thereof
11/16/2010US7833632 Nitrogenous heterocycle derivative, and organic electroluminescent element employing the same
11/16/2010CA2471220C Novel alkansulfonamides as endothelin antagonists
1 ... 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 ... 626